MC-100093, a novel β-lactam GLT-1 enhancer devoid of antimicrobial properties attenuates cocaine relapse in rats

[1]  A. Bechard,et al.  Role of prefrontal cortex projections to the nucleus accumbens core in mediating the effects of ceftriaxone on cue‐induced cocaine seeking , 2020, Addiction biology.

[2]  M. Filip,et al.  Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease , 2020, Neuroscience & Biobehavioral Reviews.

[3]  C. Tai,et al.  A new avenue for treating neuronal diseases: Ceftriaxone, an old antibiotic demonstrating behavioral neuronal effects , 2019, Behavioural Brain Research.

[4]  A. Bechard,et al.  The Effects of Clavulanic Acid and Amoxicillin on Cue-Primed Reinstatement of Cocaine Seeking , 2019, Behavioral neuroscience.

[5]  L. Knackstedt,et al.  A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors , 2018, Translational Psychiatry.

[6]  A. Bechard,et al.  The effects of ceftriaxone on cue-primed reinstatement of cocaine-seeking in male and female rats: estrous cycle effects on behavior and protein expression in the nucleus accumbens , 2017, Psychopharmacology.

[7]  K. Reissner,et al.  Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal , 2018, Neuropharmacology.

[8]  K. Reissner,et al.  Riluzole Impairs Cocaine Reinstatement and Restores Adaptations in Intrinsic Excitability and GLT-1 Expression , 2017, Neuropsychopharmacology.

[9]  R. Mccullumsmith,et al.  Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression , 2017, The Journal of Neuroscience.

[10]  P. Coleman,et al.  Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia. , 2016, Journal of medicinal chemistry.

[11]  Ana K. Weiland,et al.  Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking , 2015, Front. Pharmacol..

[12]  J. Emery,et al.  Small-Molecule Inhibitors of Staphylococcus aureus RnpA-Mediated RNA Turnover and tRNA Processing , 2015, Antimicrobial Agents and Chemotherapy.

[13]  Puneet Kumar,et al.  GLT-1 transporter: An effective pharmacological target for various neurological disorders , 2014, Pharmacology Biochemistry and Behavior.

[14]  G. Rebec,et al.  Role of the Major Glutamate Transporter GLT1 in Nucleus Accumbens Core Versus Shell in Cue-Induced Cocaine-Seeking Behavior , 2013, The Journal of Neuroscience.

[15]  Maria F. Sassano,et al.  Automated design of ligands to polypharmacological profiles , 2012, Nature.

[16]  R. LaLumiere,et al.  Ceftriaxone Normalizes Nucleus Accumbens Synaptic Transmission, Glutamate Transport, and Export following Cocaine Self-Administration and Extinction Training , 2012, The Journal of Neuroscience.

[17]  G. Tononi,et al.  Reduction of EEG Theta Power and Changes in Motor Activity in Rats Treated with Ceftriaxone , 2012, PloS one.

[18]  L. Knackstedt,et al.  Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking , 2011, Behavioural Brain Research.

[19]  M. Amore,et al.  Promising medications for cocaine dependence treatment. , 2011, Recent patents on CNS drug discovery.

[20]  F. Sörgel,et al.  Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections , 2010, Clinical Microbiology Reviews.

[21]  P. Kalivas,et al.  Ceftriaxone Restores Glutamate Homeostasis and Prevents Relapse to Cocaine Seeking , 2010, Biological Psychiatry.

[22]  G. Rebec,et al.  Upregulation of Glt1 Attenuates Cue-Induced Reinstatement of Cocaine-Seeking Behavior in Rats , 2009, The Journal of Neuroscience.

[23]  Aleksandra Galetin,et al.  Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes , 2009, Drug Metabolism and Disposition.

[24]  E. Calabrese.  U-Shaped Dose Response in Behavioral Pharmacology: Historical Foundations , 2008, Critical reviews in toxicology.

[25]  R. Sheridan,et al.  Inhibition of recombinant cytochrome P450 isoforms 2D6 and 2C9 by diverse drug-like molecules. , 2007, Journal of medicinal chemistry.

[26]  M. Jamei,et al.  Misuse of the Well-Stirred Model of Hepatic Drug Clearance , 2007, Drug Metabolism and Disposition.

[27]  David H. Epstein,et al.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure , 2006, Psychopharmacology.

[28]  Lin Lu,et al.  Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. , 2005, European journal of pharmacology.

[29]  H. Pajouhesh,et al.  Medicinal chemical properties of successful central nervous system drugs , 2005, NeuroRX.

[30]  I. Hidalgo,et al.  Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. , 2005, International journal of pharmaceutics.

[31]  P. Fisher,et al.  β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression , 2005, Nature.

[32]  C. O'brien.  Research advances in the understanding and treatment of addiction. , 2003, The American journal on addictions.

[33]  J. Cano,et al.  Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis , 1995, Antimicrobial agents and chemotherapy.

[34]  I. Pastan,et al.  A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Akaike.  A new look at the statistical model identification , 1974 .

[36]  Master Textbook,et al.  Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health , 2017 .

[37]  P. Kalivas,et al.  Chronic Administration of the Methylxanthine Propentofylline Impairs Reinstatement to Cocaine by a GLT-1-Dependent Mechanism , 2014, Neuropsychopharmacology.